Date: October 19, 2020
Time: 11:00 AM – 12:30 PM ET


On October 19, 2020, the U.S. Food and Drug Administration (FDA) will host a virtual listening session for digital health device manufacturers, developers, health care providers, researchers, and other stakeholders to learn about the Digital Health Center of Excellence (DHCoE). The FDA will discuss the purpose and functions of the DHCoE and will focus on collecting feedback from attendees.

On September 22, 2020, the FDA established the Digital Health Center of Excellence (DHCoE). The DHCoE is part of the planned evolution of the Digital Health Program in the Center for Devices and Radiological Health. It marks the beginning of a comprehensive approach to digital health technology, setting the stage for advancing and realizing the potential of digital health.

The DHCoE will empower stakeholders to advance health care by fostering responsible and high-quality digital health innovation. Its objectives include:

  • Connecting and building partnerships to accelerate digital health advancements.
  • Sharing knowledge to increase awareness and understanding, drive synergy , and advance best practices.
  • Innovating regulatory approaches to provide efficient and least burdensome oversight while meeting FDA standards.

We encourage all interested stakeholders to join. Registration is not necessary.


View Session Details


Stakeholder Call Details:
Registration is not necessary.

Date: October 19, 2020
Time: 11:00 a.m. – 12:30 p.m.

To ensure you are connected, please dial in 15 minutes before the start of the call.

U.S. Callers Dial:

Conference Number: PWXW1570473
Passcode: 1421197

International Callers Dial:

Conference Number: PWXW1570473
Passcode: 1421197
To view the slide presentation during the webinar:

Following the webinar, a transcript, recording, and slides will be provided.